Wednesday, August 4, 2021

Collaborative Communities on Medical Devices

How can you get involved in a collaborative community, a global grassroots effort convened by interested stakeholders?

If your email program has trouble displaying this email, view as a webpage.

FDA - Center for Devices and Radiological Health

Collaborative Communities on Medical Devices

The U.S. Food and Drug Administration (FDA) currently participates in 12 collaborative communities, which were established, and are managed and controlled by external stakeholders. Since January 2021, the FDA joined these collaborative communities:

  • MedTech Color Collaborative Community on Diversity and Inclusion in Medical Device Product Development and Clinical Research (MedTech Color)
  • Digital Health Measurement Collaborative Community (DATAcc)

Watch our video to learn more, including:

  • What is a collaborative community?
  • Why join a collaborative community?
  • How can I get involved in a collaborative community?
Still frame from the video showing an illustration of several figures standing in a row.

Watch the Video

Collaborative Communities with FDA Participation

The FDA reached the goal set as part of CDRH's 2018-2020 Strategic Priorities of participating in at least 10 new collaborative communities by December 31, 2020. The agency encourages medical device stakeholders to consider engaging in collaborative communities.

Questions?

If you have questions about collaborative communities, or if you have a collaborative community in which you would like the FDA to consider participating, email CDRHCollabCommunities@fda.hhs.gov.


This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

1 comment:

  1. I am really enjoying reading your well written articles. It looks like you spend a lot of effort and time on your blog. I have bookmarked it and I am looking forward to reading new articles. Keep up the good work. Lumenis

    ReplyDelete